Condition: Asthma · Sponsor: AstraZeneca
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled corticosteroids (ICS) and at least one additional asthma controller medication with or without oral corticosteroids.
This description comes directly from the study's public registry record.
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
Always discuss trial participation with your own doctor first.
| Research Site | Montgomery, Alabama, United States | Recruiting |
| Research Site | Phoenix, Arizona, United States | Recruiting |
| Research Site | Little Rock, Arkansas, United States | Withdrawn |
| Research Site | La Jolla, California, United States | Recruiting |
| Research Site | Long Beach, California, United States | Recruiting |
| Research Site | Orange, California, United States | Withdrawn |
| Research Site | San Diego, California, United States | Recruiting |
| Research Site | Atlanta, Georgia, United States | Recruiting |
| Research Site | Savannah, Georgia, United States | Terminated |
| Research Site | Baltimore, Maryland, United States | Recruiting |
| Research Site | Boston, Massachusetts, United States | Recruiting |
| Research Site | Boston, Massachusetts, United States | Recruiting |
+ 131 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06023589